Ratio Therapeutics · Series C
Chemistry Laboratory Operations Associate
Boston, Massachusetts
$70K–$90K
Posted 31 days ago· Oct 21

Biopharma, Biotechnology, Life Science, Medical, Pharmaceutical
Ratio Therapeutics raised $70M in a Series C announced on Jul 31, 2026, led by Eli Lilly, Catalio Capital Management, Bristol-Myers Squibb, Cornell University, Duquesne Family Office. Since then it has posted 4 roles (2 still open), the first 4 days after it. Another 2 open roles were posted before the announcement. With 4 open roles it is hiring more than 5% of the 83 Series C startups on JustBacked (median: 22). In total it has raised $160M over 3 rounds from 5 investors.
From Ratio Therapeutics's own hiring system, by posting date. Tracked since Oct 4, 2026; roles that closed before then aren't counted.
Ratio Therapeutics is a clinical-phase pharmaceutical company that develops radiopharmaceuticals for solid tumors.
The bet: one targeting platform, Ratio Therapeutics' Trillium, can both image and treat tumors, so a single scan could pick the patients and the drug. If it works, Boston-based radiopharmaceuticals could move from a niche option to a routine tool against many solid tumors. Eli Lilly and Bristol-Myers Squibb back a $70M Series C, bigger than 34% of rounds at its stage this half, for a clinical-phase company.
JustBacked's take, based on Ratio Therapeutics's own site and its funding and hiring data.
Hiring velocity
Where they're hiring
Ratio Therapeutics · Series C
Boston, Massachusetts
$70K–$90K
Posted 31 days ago· Oct 21
Ratio Therapeutics · Series C
West Valley City, Utah
$90K–$120K
Posted 88 days ago· Aug 25
Ratio Therapeutics · Series C
West Valley City, Utah
$130K–$165K
Posted 162 days ago· Jun 12
Ratio Therapeutics · Series C
Boston, Massachusetts
Posted 1403 days ago· Jan 18
Source: ratiotx.com, checked daily.